Anxiety spectrum disorders
exp date isn't null, but text field is
|
Generalised anxiety disorder (GAD) |
Panic disorder |
Post-traumatic stress disorder (PTSD) |
Obsessive-compulsive disorder |
Social phobia |
Clinical presentation |
- irrational worries |
- sudden unpredictable episodes of severe anxiety |
- history of a traumatic life event (as perceived by the sufferer) |
- obsessional thinking (eg constantly thinking that the door has been left unlocked) |
- extreme fear of social situations (eg eating in public places or public speaking) |
Emergency management |
Benzodiazepines (normally for short-term use only: max 2 to 4 weeks, very rarely long-term). |
Benzodiazepines (have a rapid effect, although panic symptoms return quickly if the drug is withdrawn). |
Not usually appropriate. |
Not usually appropriate. |
Benzodiazepines (have a rapid effect and may be useful on a ‘when required’ basis). |
Non-drug treatments See: ‘The Matrix – 2015 A guide to delivering evidence-based Psychological Therapies in Scotland’ (https://www.nes.scot.nhs.uk) These are equally as effective as drug treatment. |
Best evidence is for guided self-help or group psychoeducation (eg Stresspac/www.llttf.com) for mild cases. CBT* for moderate or severe cases. |
Best evidence is for guided self-help (bibliotherapy or via internet (eg www.llttf.com) in mild cases). For moderate panic disorder consider individual CBT* which can be augmented with bibliotherapy, internet/computer packages and/or group CBT*. In more severe cases, individual CBT* (up to 20 sessions) supplemented with written material. |
Best evidence is for brief trauma-focussed CBT* if presentation is mild (although this should not be offered to asymptomatic patients as a preventative measure). Beyond mild presentations, trauma-focussed CBT or Eye Movement Desensitisation and Reprocessing (EMDR) are both well supported. |
Best evidence is for CBT*, which should incorporate Exposure and Response Prevention (Ex/RP). This holds across all levels of severity. Combined drug and psychological therapy may be the most effective option. |
Best evidence is for guided self-help for mild cases (bibliotherapy or via internet). For moderate and severe cases, consider either behavioural therapy (incorporating exposure) or CBT* (incorporating exposure and cognitive restructuring). If presentation is severe enough to meet criteria for avoidant personality disorder, consider CBT (20 sessions). |
Drug treatment Treatment of anxiety may prevent the subsequent development of depression. See section 4.1 and Guidance for the treatment of GAD. |
First choice: sertraline or alternative SSRI** (although may initially exacerbate symptoms. A lower starting dose of 25mg sertraline is often required). Second-line antidepressant: venlafaxine or mirtazapine Referral for specialist advice (options include alternative antidepressants, pregabalin***, duloxetine*** or antipsychotic). |
NICE do not recommend benzodiazepines. SSRIs** (therapeutic effect can be delayed and patients can experience an initial exacerbation of panic symptoms). Referral for specialist advice. |
SSRIs** Referral for specialist advice. (Prazosin for nightmares (should not be sole treatment for PTSD). |
SSRIs** Clomipramine. Referral for specialist advice. |
SSRIs** Referral for specialist advice. |
*Cognitive behavioural therapy (CBT): GP referral for CBT via SCI gateway or free telephone service, GP or self-referral, to NHS Living Life (tel: 0800 328 9655)
** Selective serotonin reuptake inhibitors. If using citalopram note cautions on its use; see www.gov.uk/drug-safety-update
*** For specialist initiation only: pregabalin and duloxetine are licensed for the treatment of GAD however the manufacturers have not made a submission to SMC in this indication and consequently neither has received a recommendation for this use in NHS Scotland. For pregabalin: use twice daily dosing and higher strength capsules as appropriate, to minimise capsule burden.